MicroSyne Medical

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

MicroSyne Medical - overview

Established

2024

Location

Shanghai, -, China

Primary Industry

Medical Devices & Equipment

About

Based in Shanghai, China and founded in 2024, Maikewei Interactive Medical Technology (Shanghai) Co. , Ltd. , trading as MicroSyne Medical, is a neuromodulation-focused medical technology company specializing in the industrialization of non‑invasive brain–computer interface (BCI) technologies for neurological regulation. In March 2026, MicroSyne Medical raised an angel funding from Dalton Venture.


The company develops wearable neuromodulation products, and its core product is the wearable neurostimulator. The company is also advancing its innovative product pipeline, such as the tibial nerve stimulation system, and continuing to expand into more areas of neurological diseases. The company's revenue is generated by providing wearable neuromodulation products. The company will use the funding to expand the indications for the core product – wearable neurostimulators, advance multi-center clinical trials, and expand domestic and international markets, thereby accelerating the industrialization of non-invasive brain-computer interface (BCI) technology in the field of neuromodulation.


Current Investors

Dalton Venture

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare Specialists, Therapeutic Devices

Verticals

HealthTech, Wearables & Quantified Self

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.